Sarissa Capital Management
Latest statistics and disclosures from Sarissa Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are INVA, IRWD, AMRN, NBIX, CYTK, and represent 86.60% of Sarissa Capital Management's stock portfolio.
- Added to shares of these 1 stock: BHVN.
- Reduced shares in these 5 stocks: NBIX (-$25M), IRWD (-$24M), INVA (-$16M), CYTK (-$11M), LNTH.
- Sarissa Capital Management was a net seller of stock by $-76M.
- Sarissa Capital Management has $158M in assets under management (AUM), dropping by -29.28%.
- Central Index Key (CIK): 0001577524
Tip: Access up to 7 years of quarterly data
Positions held by Sarissa Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 9 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Innoviva (INVA) | 31.5 | $50M | -24% | 2.1M | 23.30 |
|
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 20.5 | $32M | -42% | 9.2M | 3.51 |
|
| Amarin Corp Sponsored Adr (AMRN) | 15.4 | $24M | 1.7M | 14.46 |
|
|
| Neurocrine Biosciences (NBIX) | 9.7 | $15M | -61% | 117k | 131.74 |
|
| Cytokinetics Com New (CYTK) | 9.6 | $15M | -42% | 229k | 65.91 |
|
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 8.0 | $13M | -8% | 167k | 75.85 |
|
| Biohaven (BHVN) | 3.0 | $4.8M | +9% | 563k | 8.46 |
|
| Regeneron Pharmaceuticals (REGN) | 2.1 | $3.2M | 4.2k | 772.64 |
|
|
| Vor Biopharma Com New (VOR) | 0.3 | $453k | 25k | 17.84 |
|
Past Filings by Sarissa Capital Management
SEC 13F filings are viewable for Sarissa Capital Management going back to 2013
- Sarissa Capital Management 2026 Q1 filed May 15, 2026
- Sarissa Capital Management 2025 Q4 filed Feb. 17, 2026
- Sarissa Capital Management 2025 Q3 filed Nov. 14, 2025
- Sarissa Capital Management 2025 Q2 filed Aug. 14, 2025
- Sarissa Capital Management 2025 Q1 filed May 15, 2025
- Sarissa Capital Management 2024 Q4 filed Feb. 14, 2025
- Sarissa Capital Management 2024 Q3 filed Nov. 14, 2024
- Sarissa Capital Management 2024 Q2 filed Aug. 14, 2024
- Sarissa Capital Management 2024 Q1 filed May 15, 2024
- Sarissa Capital Management 2023 Q4 filed Feb. 14, 2024
- Sarissa Capital Management 2023 Q3 filed Nov. 14, 2023
- Sarissa Capital Management 2023 Q2 filed Aug. 14, 2023
- Sarissa Capital Management 2023 Q1 filed May 15, 2023
- Sarissa Capital Management 2022 Q4 filed Feb. 14, 2023
- Sarissa Capital Management 2022 Q3 filed Nov. 14, 2022
- Sarissa Capital Management 2022 Q2 filed Aug. 15, 2022